SCHEMBL17952990

SCHEMBL17952990

CC1=Cc2c(-c3cccc4ccccc34)cccc2C1CC1C(C)=Cc2c1cccc2N1CCc2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.34
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
NCOR2 Q9Y618 1/20 0.33
HTR7 P34969 3/20 0.33
HTR1A P08908 2/20 0.33
SLC6A4 P31645 2/20 0.32
CYP2D6 P10635 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HSD17B10 Q99714 3/20 0.31
SRD5A1 P18405 2/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 2/20 0.31
ROCK1 Q13464 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
DRD2 P14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17952984 0.94 CHRM2 (0.34) SMN1; SMN2HDAC3HDAC1HDAC2HDAC8
SCHEMBL17169024 0.88 SMN1; SMN2 (0.39) SMN1; SMN2HSD17B10SRD5A1ALDH1A1HPGD
SCHEMBL17952985 0.86 DRD2 (0.34) SMN1; SMN2HTR7HTR1AHSD17B10SRD5A1
SCHEMBL19336713 0.86 SMN1; SMN2 (0.34) SMN1; SMN2HDAC3HDAC1HDAC2HDAC8
SCHEMBL17082307 0.85 HTR7 (0.34) SMN1; SMN2HDAC3HDAC1HDAC2HDAC8
SCHEMBL17952987 0.84 JAK2 (0.38) SMN1; SMN2SRD5A1ALDH1A1HPGDROCK1
SCHEMBL17074017 0.84 SMN1; SMN2 (0.32) SMN1; SMN2HDAC3HDAC1HDAC2HDAC8
SCHEMBL17952994 0.83 HTR7 (0.33) HTR7HTR1ASLC6A4CYP2D6SLC6A2
SCHEMBL7039658 0.82 ALDH1A1 (0.36) HTR7HTR1ASLC6A4CYP2D6SLC6A2
SCHEMBL17169025 0.81 MEN1 (0.38) SMN1; SMN2SRD5A1ALDH1A1HPGDROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790240-B2 Ligand compound, a preparation method thereof, a transition metal compound, and a preparation method thereof LG CHEM, LTD. (KR) 2017-10-17 US disclosed
US-20160215004-A1 A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND, AND A PREPARATION METHOD THEREOF LG CHEM, LTD. (KR) 2016-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160215004-A1 A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND, AND A PREPARATION METHOD THEREOF CD40LG, OSTC, TNFSF10 SMN1; SMN2 4715/4885HDAC3 4183/4885HDAC1 3219/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.